Keefer LK[au] - Search Results

Year	Number of Results
1967	1
1970	1
1971	1
1972	1
1973	2
1975	1
1976	2
1977	2
1978	2
1979	1
1980	3
1981	1
1982	3
1983	5
1984	1
1985	3
1986	2
1987	7
1988	4
1989	3
1990	5
1991	8
1993	9
1994	5
1995	4
1996	9
1997	5
1998	1
1999	3
2000	7
2001	13
2002	9
2003	8
2004	4
2005	9
2006	7
2007	11
2008	15
2009	7
2010	19
2011	15
2012	12
2013	6
2014	7
2015	4
2021	0

1

Fifty years of diazeniumdiolate research. From laboratory curiosity to broad-spectrum biomedical advances.

Keefer LK. Keefer LK. ACS Chem Biol. 2011 Nov 18;6(11):1147-55. doi: 10.1021/cb200274r. Epub 2011 Sep 30. ACS Chem Biol. 2011. PMID: 21932836 Free PMC article. Review.

2

A new approach to measuring estrogen exposure and metabolism in epidemiologic studies.

Ziegler RG, Faupel-Badger JM, Sue LY, Fuhrman BJ, Falk RT, Boyd-Morin J, Henderson MK, Hoover RN, Veenstra TD, Keefer LK, Xu X. Ziegler RG, et al. Among authors: keefer lk. J Steroid Biochem Mol Biol. 2010 Aug;121(3-5):538-45. doi: 10.1016/j.jsbmb.2010.03.068. Epub 2010 Apr 9. J Steroid Biochem Mol Biol. 2010. PMID: 20382222 Free PMC article. Review.

3

Broad-Spectrum Anti-Cancer Activity of O-Arylated Diazeniumdiolates.

Keefer LK; behalf of the JS-K Consortium. Keefer LK, et al. For Immunopathol Dis Therap. 2010 Jul 1;1(3):205-218. doi: 10.1615/ForumImmunDisTher.v1.i3.30. For Immunopathol Dis Therap. 2010. PMID: 21949595 Free PMC article.

4

Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates.

Keefer LK. Keefer LK. Annu Rev Pharmacol Toxicol. 2003;43:585-607. doi: 10.1146/annurev.pharmtox.43.100901.135831. Epub 2002 Jan 10. Annu Rev Pharmacol Toxicol. 2003. PMID: 12415121 Review.

5

In memoriam: Christopher J. Michejda (December 19, 1937-January 9, 2007).

Tarasova NI, Loeppky RN, Byrd RA, Keefer LK. Tarasova NI, et al. Among authors: keefer lk. Chem Res Toxicol. 2007 Mar;20(3):323-5. doi: 10.1021/tx700056k. Epub 2007 Mar 3. Chem Res Toxicol. 2007. PMID: 17335248 No abstract available.

6

Diazeniumdiolates: pro- and antioxidant applications of the "NONOates".

Fitzhugh AL, Keefer LK. Fitzhugh AL, et al. Among authors: keefer lk. Free Radic Biol Med. 2000 May 15;28(10):1463-9. doi: 10.1016/s0891-5849(00)00251-3. Free Radic Biol Med. 2000. PMID: 10927170 Review.

7

Chemistry of the nitric oxide-releasing diazeniumdiolate ("nitrosohydroxylamine") functional group and its oxygen-substituted derivatives.

Hrabie JA, Keefer LK. Hrabie JA, et al. Among authors: keefer lk. Chem Rev. 2002 Apr;102(4):1135-54. doi: 10.1021/cr000028t. Chem Rev. 2002. PMID: 11942789 Review. No abstract available.

8

Direct reaction of amides with nitric oxide to form diazeniumdiolates.

Holland RJ, Klose JR, Deschamps JR, Cao Z, Keefer LK, Saavedra JE. Holland RJ, et al. Among authors: keefer lk. J Org Chem. 2014 Oct 3;79(19):9389-93. doi: 10.1021/jo501670e. Epub 2014 Sep 22. J Org Chem. 2014. PMID: 25210948 Free PMC article.

9

Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): emerging commercial opportunities.

Keefer LK. Keefer LK. Curr Top Med Chem. 2005;5(7):625-36. doi: 10.2174/1568026054679380. Curr Top Med Chem. 2005. PMID: 16101424 Review.

10

Glycosylated PROLI/NO derivatives as nitric oxide prodrugs.

Nandurdikar RS, Maciag AE, Hong SY, Chakrapani H, Citro ML, Keefer LK, Saavedra JE. Nandurdikar RS, et al. Among authors: keefer lk. Org Lett. 2010 Jan 1;12(1):56-9. doi: 10.1021/ol902481s. Org Lett. 2010. PMID: 19954198 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results